Better Intra-Agency Reviews Could Speed FDA Seizure, Injunction Decisions
This article was originally published in The Tan Sheet
Executive Summary
FDA is working to expedite its decision-making process for seizures and injunctions, which could translate into quicker enforcement actions for violative products.
You may also be interested in...
H&P/Triad Stops OTC Manufacturing In Consent Decree With FDA
FDA forbids Triad Group, H&P Industries and three employees from manufacturing or distributing OTC products until they comply with good manufacturing practices.
H&P/Triad Stops OTC Manufacturing In Consent Decree With FDA
FDA forbids Triad Group, H&P Industries and three employees from manufacturing or distributing OTC products until they comply with good manufacturing practices.
H&P/Triad Stops OTC Manufacturing In Consent Decree With FDA
FDA forbids Triad Group, H&P Industries and three employees from manufacturing or distributing OTC products until they comply with good manufacturing practices.